Report of Foreign Issuer (6-k)
21 Setembro 2018 - 11:03AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF A
FOREIGN ISSUER
PURSUANT TO RULE
13A-16
OR
15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For September 21, 2018
Commission File Number
1-38455
MorphoSys AG
Semmelweisstrasse 7
82152 Planegg
Germany
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☒ Form
40-F ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule
12g3-2(b)
under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b):
Notification of managers`transactions according to article 19 MAR
Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
|
|
|
|
|
a)
|
|
Name
|
|
Dr. Simon Moroney
|
|
|
|
|
|
|
|
2
|
|
Reason for the notification
|
|
|
|
|
|
|
|
a)
|
|
Position/status
|
|
Member of the managing body
|
|
|
|
|
|
|
b)
|
|
Initial notification/Amendment
|
|
Initial notification
|
|
|
|
|
|
|
3
|
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
|
|
|
|
|
a)
|
|
Name
|
|
MorphoSys AG
|
|
|
|
|
|
|
|
|
b)
|
|
LEI
|
|
529900493806K77LRE72
|
|
|
|
|
|
|
4
|
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
|
|
|
|
|
|
a)
|
|
Description of the financial instrument. type of instrument
Identification code
|
|
Shares ISIN DE0006632003
|
|
|
|
|
|
|
|
b)
|
|
Nature of the transaction
|
|
Disposal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
c)
|
|
Price(s) and volume(s)
|
|
Preis
|
|
|
Volumen
|
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
8.585,85
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
4.717,50
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
4.717,50
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
14.624,25
|
€
|
|
|
|
|
|
|
|
|
94,30
|
€
|
|
|
15.748,10
|
€
|
|
|
|
|
|
|
|
|
94,25
|
€
|
|
|
17.719,00
|
€
|
|
|
|
|
|
|
|
|
94,25
|
€
|
|
|
13.666,25
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
9.246,30
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
5.094,90
|
€
|
|
|
|
|
|
|
|
|
94,35
|
€
|
|
|
188,70
|
€
|
|
|
|
|
|
|
|
|
94,60
|
€
|
|
|
4.446,20
|
€
|
|
|
|
|
|
|
|
|
94,40
|
€
|
|
|
2.737,60
|
€
|
|
|
|
|
|
|
|
|
94,40
|
€
|
|
|
44.462,40
|
€
|
|
|
|
|
|
|
|
|
94,20
|
€
|
|
|
4.898,40
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
9.400,00
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
37.600,00
|
€
|
|
|
|
|
|
|
|
|
93,80
|
€
|
|
|
29.734,60
|
€
|
|
|
|
|
|
|
|
|
93,80
|
€
|
|
|
17.165,40
|
€
|
|
|
|
|
|
|
|
|
94,20
|
€
|
|
|
42.201,60
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
9.306,00
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
37.694,00
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
153.126,00
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
6.580,00
|
€
|
|
|
|
|
|
|
|
|
94,00
|
€
|
|
|
21.526,00
|
€
|
|
|
|
|
|
|
|
|
|
d)
|
|
Aggregated information
•
Aggregated volume
•
Price
|
|
|
515.186,55€
94,10€
|
|
|
|
|
|
|
|
|
|
|
|
|
|
e)
|
|
Date of the transaction
|
|
|
2018-09-19;
UTC+2
|
|
|
|
|
|
|
|
|
|
f)
|
|
Place of the transaction
|
|
|
XETRA
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
MORPHOSYS AG (Registrant)
|
|
|
|
|
|
Date: September 21, 2018
|
|
By:
|
|
/s/ Jens Holstein
|
|
|
|
|
|
Name:
|
|
Jens Holstein
|
|
|
|
|
|
Title:
|
|
CFO
|
|
|
|
|
|
|
|
By:
|
|
/s/ Hans-Joachim Orlowski
|
|
|
|
|
|
Name:
|
|
Hans-Joachim Orlowski
|
|
|
|
|
|
Title:
|
|
Associate Director Corporate Communications and Investor Relations
|
MorphoSys (NASDAQ:MOR)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
MorphoSys (NASDAQ:MOR)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
